Pages that link to "Item:Q5442623"
From MaRDI portal
The following pages link to Uses and limitations of randomization-based efficacy estimators (Q5442623):
Displaying 7 items.
- The interpretation of clinical trials of immediate versus delayed therapy (Q1273845) (← links)
- Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial (Q3303671) (← links)
- Uses and limitations of randomization-based efficacy estimators (Q5424959) (← links)
- Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis (Q5424960) (← links)
- Why There's No Cause to Randomize (Q5426529) (← links)
- Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis (Q5442624) (← links)
- Estimation of treatment effect in presence of noncompliance with early or late switching: a simulation study (Q6141695) (← links)